ehave,

Telehealth: Contactless Health Screening from Ehave (EHVVF) and VastMinz.

Contactless Health Screening Ehave acquires License covering G-20 Countries for all Psychedelic use, AI-Powered Telehealth Technology To Capture Physiological...

Citius Pharmaceuticals, Inc. (CTXR) Reports Fiscal Full Year 2023 Financial Results and Provides Business...

Mino-Lok® Pivotal Phase 3 trial enrollment completed; topline data expected 2Q 2024 LYMPHIR™ BLA resubmission on track for early 2024

Revive Therapeutics (RVVTF) Regulatory Update Archive.

April 12th, 2022 update. Discusses potentially halting the Study early due to positive efficacy based on other clinical outcomes evaluated such as...
Hapbee, EMulate, HAPB

A Medical Technology That Has The Highest Potential Over Any We Follow.

You Must Read This... New Report on the People Behind EMulate Therapeutics. 200 Million...
Good Clinic, Biotech Stock Review

Mitesco (MITI) $0.45 to Open its First Medical Clinic.

LIVE QUOTE Nice chart ahead of its first clinic opening.. By George, they did...

Ranked: The Most Popular Drugs in the U.S.

Sorting the annual prescribed medicines data by the total number of patients highlights how important and prevalent some drugs are in America.

Interview: Ric Schumacher CEO, Pressure Bioscience (PBIO)

Our favorite interview to date, and there have been dozens. Filmed November of 2021, and the story has gotten to much better...

Greatest Interview with Arthur Hayes.

38-year-old Arthur Hayes who hails from Detroit, with a estimated net worth of $500 million, and has posted a fantastic interview. It's...
Revive Therapeutics

Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict for Its Novel Covid...

Two Binary Events Directly Ahead. As in Months Away, not Years. Share Price up 76% During April.

Beachbody (BODY) Conference Call

"Make no mistake, as the single largest shareholder as well as CEO of Beachbody, but more so because I believe in the...

Latest article

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...